Back to top
loading...
Top ETFs & Stocks from Top-Ranked Sectors

Top ETFs & Stocks from Top-Ranked Sectors

Wall Street has staged a strong comeback, leaving the rest of the world behind. Booming tech as well as unprecedented stimulus packages have been the primary reasons for outperformance.

Wall Street has staged a strong comeback, leaving ...

A "Don't Fight the Fed" Rally: Zacks June Strategy

A "Don't Fight the Fed" Rally: Zacks June Strategy

In early May, international travel shutdowns remained the norm. Some U.S. state governors gingerly lifted their "Stay-at-Home" decrees. Now all 50 U.S. states are open for business.

In early May, international travel shutdowns remained the ...

New Strong Buy Stocks for June 5th

New Strong Buy Stocks for June 5th

This biopharmaceutical company has seen the Zacks Consensus Estimate for its current year earnings increasing 86.1% over the last 60 days.

This biopharmaceutical company has seen the Zacks Consensus ...

Russell 2000 Soars 50% in Less Than 3 Months: 5 Top Picks

Russell 2000 Soars 50% in Less Than 3 Months: 5 Top Picks

The small-cap index has been performing strongly. Several small-cap stocks have skyrocketed more than 30% in the past month. We have selected 5 with a favorable Zacks Rank and strong growth potential.

The small-cap index has been performing strongly. Several ...

Investment Ideas

Stocks

ETFs

Mutual Funds

Options

Earnings Analysis

More Analysis

Earnings Headlines

View All

Reported Earnings Surprises

View All
Symbol Time Expected Reported %Surprise

EPS Positive Surprises for Jun 6, 2020

Symbol Time Expected Reported %Surprise
TPCO 07:54 -0.07 -0.99 -1,314.29

EPS Negative Surprises for Jun 6, 2020

Upcoming Earnings ESP

View More
Symbol ESP Most Accurate Estimate Consensus Estimate
CASY 2.58% 1.89 1.84
THO 78.54% -0.17 -0.43
PLAY 14.46% -0.69 -0.81
GES 12.75% -0.77 -0.88

Video Commentaries

One Stock Opportunity Stands Out Despite An ‘Overbought’ Market

One Stock Opportunity Stands Out Despite An ‘Overbought’ Market

We are trading at very frothy levels with all of the technical indicators pointing to overbought. Yet, there is one pharmaceutical stock that may still be a buy. Edit: Merck\'s management cut 2020 EPS guidance only marginally (7%) due to the COVID crisis.

We are trading at very frothy levels with ...

Zacks Partner Headlines

thestreet

marketwatch

cnn